Arrowhead Pharmaceuticals Inc ARWR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/02/24 EDT
24.13quote price arrow up+0.96 (+4.14%)
Volume
836,334
52 week range
20.67 - 42.48
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.13
  • 52 Week High42.48
  • 52 Week High Date05/05/23
  • 52 Week Low20.67
  • 52 Week Low Date12/01/23

Key Stats

  • Market Cap2.99B
  • Shares Out123.90M
  • 10 Day Average Volume0.96M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change-21.14

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.13
  • 52 Week High42.48
  • 52 Week High Date05/05/23
  • 52 Week Low20.67
  • 52 Week Low Date12/01/23
  • Market Cap2.99B
  • Shares Out123.90M
  • 10 Day Average Volume0.96M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change-21.14

RATIOS/PROFITABILITY

  • EPS (TTM)-2.77
  • P/E (TTM)-8.71
  • Fwd P/E (NTM)-11.36
  • EBITDA (TTM)-285.321M
  • ROE (TTM)-110.45%
  • Revenue (TTM)181.74M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-166.63%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arrowhead Pharmaceuticals Inc

 

Profile

MORE
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting...
Douglass Given M.D., Ph.D.
Independent Chairman of the Board
Christopher Anzalone Ph.D.
President, Chief Executive Officer, Director
Patrick O'Brien J.D.
Chief Operating Officer, General Counsel, Company Secretary
Kenneth Myszkowski
Chief Financial Officer
Address
177 E Colorado Blvd, Suite 700
Pasadena, CA
91105
United States

Top Peers

SYMBOLLASTCHG%CHG
MOR
MorphoSys AG
17.87+0.36+2.06%
IMCR
Immunocore Holdings PLC
59.46+0.41+0.69%
VCEL
Vericel Corp
47.88+0.80+1.70%
ACLX
Arcellx Inc
53.29+1.11+2.13%
MRUS
Merus NV
47.50+0.48+1.02%